News & Insights
Comparing & Contrasting the Divergent Litigation Pathways of Small vs. Large Molecule Products: Examining the Impact of Differing Regulatory Schemes, Challenges Created Under the AIA & Lessons Learned from Recent Biosimilars Litigation in the US & Abroad
New York, NY
September 23, 2013
Event Sponsor: The International Congress on Paragraph IV Litigation
SIGNAL Group (formerly McBee Strategic Consulting, LLC) is a wholly owned subsidiary of Wiley Rein. SIGNAL is a total solutions provider—advocacy, strategic communications, research, and digital media—for clients seeking to engage the federal government to achieve competitive advantage, influence public policy, establish new markets, and secure public capital.